WCG
DGX icon

Weaver Consulting Group’s Quest Diagnostics DGX Stock Holding History

Weaver Consulting Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-49
Closed -$6K – 319
2020
Q3 		$6K Hold
49
– – ﹤0.01% 655
2020
Q2 		$6K Hold
49
– – ﹤0.01% 624
2020
Q1 		$4K Hold
49
– – ﹤0.01% 593
2019
Q4 		$5K Hold
49
– – ﹤0.01% 600
2019
Q3 		$5K Hold
49
– – ﹤0.01% 584
2019
Q2 		$5K Hold
49
– – ﹤0.01% 569
2019
Q1 		$5K Buy
+49
New +$4.25K ﹤0.01% 1106

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Weaver Consulting Group's DGX Position: Q4 2020 in Review

Weaver Consulting Group sold out of Quest Diagnostics (DGX) in Q4 2020, closing a stake of 49 shares — an estimated $6K sold.

Weaver Consulting Group first reported a position in DGX in Q1 2019 and held it in 7 quarters. The position peaked at $6K in Q3 2020. 811 funds tracked by Wall St. Rank hold DGX as of Q4 2020.

  • Weaver Consulting Group reported no remaining Quest Diagnostics position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 49 Quest Diagnostics shares in Q4 2020, an estimated $6K.
  • Weaver Consulting Group first reported a position in Quest Diagnostics in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's Quest Diagnostics position peaked at $6K in Q3 2020.
  • 811 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.